Darvocet Side Effects

Warnings & Recalls for Darvocet

Darvocet Treatment and Use

Darvocet, or dextropropoxyphene (generic), is a weak opioid narcotic medication that was used from 1957-2010 (U.S.) to treat mild to moderate pain. It is still in use in parts of the world outside of the United States and Europe and is manufactured by Eli Lilly and Company.

Dextropropoxyphene is composed of acetaminophen (the same active ingredient in Tylenol) and propoxyphene, an opioid pain reliever. It belongs to a class of drugs known as narcotic analgesics and acts by changing the way the brain perceives pain. This means that although the pain mechanism is still in motion, your Darvocet-affected brain doesn’t quite tell you that it hurts.

How is (was) Darvocet administered?

This is kind of a trick question. Darvocet is no longer administrable in the United States and in the European Union. Before the Darvocet recall (and in parts of the world that are still able to get a hold of it), dextropropoxyphene was available as Darvocet N-50, Darvocet N-100, and Darvocet A500 tablets, as well as the Darvon capsules. Maximum daily doses (administered orally) were not to exceed 600 mg. of the propoxyphene, and 4,000 mg of the acetaminophen.

Other Names for Darvocet

• Darvocet

• Propoxyphene napsylate and acetaminophen

Lawsuits & Legal Information for Darvocet